These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6179881)

  • 1. Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients.
    Yoneyama T; Hagiwara A; Hara M; Shimojo H
    Infect Immun; 1982 Jul; 37(1):46-53. PubMed ID: 6179881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin.
    Hara M; Hagiwara A; Yoneyama T; Saito Y; Shimojo H
    Microbiol Immunol; 1983; 27(12):1057-65. PubMed ID: 6328228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of strains of type 3 poliovirus by oligonucleotide mapping.
    Minor PD
    J Gen Virol; 1982 Apr; 59(Pt 2):307-17. PubMed ID: 6281371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
    Kew OM; Nottay BK; Hatch MH; Nakano JH; Obijeski JF
    J Gen Virol; 1981 Oct; 56(Pt 2):337-47. PubMed ID: 6273502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic and biochemical characterization of poliovirus type 2 isolated from two cases of paralytic disease.
    Fiore L; Pierangeli A; Lombardi F; Santoro R; Crainic R; Venuti A; Perez-Bercoff R
    Intervirology; 1987; 27(4):196-204. PubMed ID: 2447031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee.
    Minor PD; John A; Ferguson M; Icenogle JP
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():693-706. PubMed ID: 2420925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and biochemical characterization of poliovirus type 1 isolates.
    Hara M; Arita M; Yamazaki Z; Hagiwara A; Saito Y
    Microbiol Immunol; 1987; 31(4):327-36. PubMed ID: 3039316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative biochemical studies of type 3 poliovirus.
    Minor PD
    J Virol; 1980 Apr; 34(1):73-84. PubMed ID: 6246264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of the genome of poliovirus type 3 isolated from patients with poliomyelitis in Moldavia].
    Lipskaia GIu; Seĭbil' VB; Malyshkina LP; Gidirim VN; Drozdov SG
    Mol Gen Mikrobiol Virusol; 1985 Sep; (9):27-32. PubMed ID: 3025721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural proteins of poliovirus type 2 isolates.
    Yoneyama T; Hagiwara A; Hara M
    Microbiol Immunol; 1981; 25(6):575-83. PubMed ID: 6268945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
    Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
    BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
    Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
    Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolation of recombinant vaccine strains of poliovirus from patients with poliomyelitis].
    Kutitova OK; Lipskaia GIu; Maslova SV; Agol VI
    Mol Gen Mikrobiol Virusol; 1989 Nov; (11):14-20. PubMed ID: 2560812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The nature of virus strains isolated from patients with poliomyelitis in the Byelorussian SSR 1967-1985].
    Lipskaia GIu; Kutitova OK; Fel'dman EV; Votiakov VI; Maslova SV
    Mol Gen Mikrobiol Virusol; 1987 Oct; (10):30-7. PubMed ID: 2448613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
    J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees.
    Macadam AJ; Arnold C; Howlett J; John A; Marsden S; Taffs F; Reeve P; Hamada N; Wareham K; Almond J
    Virology; 1989 Oct; 172(2):408-14. PubMed ID: 2552655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
    Crainic R; Blondel B; Aubert-Combiescu A; Beytout D; Couillin P; Candrea A; Boué A; Horaud F
    Dev Biol Stand; 1984; 57():165-70. PubMed ID: 6084607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland.
    Hughes PJ; Evans DM; Minor PD; Schild GC; Almond JW; Stanway G
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2093-102. PubMed ID: 3020156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
    Georgopoulou A; Markoulatos P
    Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.